BLFS
BIOLIFE SOLUTIONS INCCompany Information
- Company Name
- BIOLIFE SOLUTIONS INC
- CIK
- CIK0000834365
- Category
- Large accelerated filer
- Ticker: Exchange
- BLFS: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- BLFS
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-10-19
- Last sale
- 2026-05-21
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 3,547,139
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 42,647,221
- Shares outstanding
- 48,866,822
- Ownership
- 87.27%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- 7.22%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 24 | 23 | 33 | 29 | 32 | 67 | 92 | 24 | 22 | 30 | 28 | 19 | ||||||
| Restricted Cash Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Available For Sale Securities Debt Securities Current | 58 | 58 | 56 | 49 | 50 | 22 | 9 | 10 | 12 | 16 | 16 | 22 | ||||||
| Accounts Receivable Net Current | 11 | 13 | 8 | 11 | 10 | 9 | 8 | 18 | 18 | 19 | 8 | 25 | ||||||
| Inventory Net | 36 | 33 | 30 | 28 | 28 | 28 | 29 | 32 | 32 | 43 | 27 | 43 | ||||||
| Prepaid Expense And Other Assets Current | 7 | 6 | 10 | 9 | 6 | 6 | 6 | 5 | 3 | 4 | 5 | 8 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | - | - | 0 | - | - | - | 5 | 0 | 0 | - | 37 | - | ||||||
| Assets Current | 135 | 133 | 137 | 127 | 125 | 131 | 149 | 89 | 88 | 112 | 121 | 117 | ||||||
| Property Plant And Equipment Net | 15 | 15 | 15 | 11 | 8 | 7 | 6 | 18 | 17 | 21 | 6 | 21 | ||||||
| Operating Lease Right Of Use Asset | 9 | 7 | 7 | 8 | 10 | 10 | 11 | 14 | 10 | 11 | 7 | 13 | ||||||
| Finance Lease Right Of Use Asset | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Deposits Assets Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 3 | 3 | 3 | 2 | - | - | 0 | - | - | - | - | - | ||||||
| Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Noncurrent | 31 | 30 | 31 | 19 | 18 | 19 | 5 | 5 | 3 | 1 | 1 | 1 | ||||||
| Equity Method Investments | - | - | 0 | 0 | 0 | 1 | 1 | - | - | - | 5 | - | ||||||
| Intangible Assets Net Excluding Goodwill | 4 | 4 | 4 | 7 | 8 | 9 | 6 | 18 | 19 | 20 | 12 | 22 | ||||||
| Deferred Income Tax Assets Net | 42 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Goodwill | 209 | 209 | 209 | 212 | 212 | 212 | 209 | 225 | 225 | 225 | 212 | 225 | ||||||
| Disposal Group Including Discontinued Operation Assets Noncurrent | - | - | 0 | - | - | - | 14 | 0 | 0 | - | 43 | - | ||||||
| Assets | 447 | 401 | 406 | 392 | 387 | 395 | 399 | 382 | 375 | 402 | 413 | 411 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 4 | 1 | 3 | 3 | 3 | 3 | 4 | 4 | 5 | 2 | 12 | ||||||
| Taxes Payable Current | 2 | 2 | 2 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 4 | 5 | ||||||
| Product Warranty Accrual Classified Current | - | - | - | - | - | - | - | 0 | 0 | 8 | 8 | 8 | ||||||
| Operating Lease Liability Current | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 3 | 3 | 3 | 1 | 3 | ||||||
| Finance Lease Liability Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Long Term Debt Current | 0 | 2 | 5 | 7 | 10 | 10 | 11 | 12 | 11 | 9 | 6 | 5 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | - | - | 0 | - | - | - | 1 | 0 | 0 | - | 19 | - | ||||||
| Liabilities Current | 14 | 18 | 23 | 27 | 28 | 28 | 33 | 32 | 31 | 39 | 42 | 43 | ||||||
| Operating Lease Liability Noncurrent | 13 | 10 | 11 | 11 | 12 | 12 | 13 | 15 | 11 | 13 | 9 | 14 | ||||||
| Business Combination Contingent Consideration Liability Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Finance Lease Liability Noncurrent | - | - | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 | ||||||
| Long Term Debt Noncurrent | - | - | 0 | 0 | 0 | 2 | 5 | 8 | 10 | 16 | 18 | 21 | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Deferred Income Tax Liabilities Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | - | - | - | 0 | - | - | - | 0 | 0 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Noncurrent | - | - | 0 | - | - | - | 0 | 0 | 0 | - | 7 | - | ||||||
| Liabilities | 27 | 29 | 34 | 38 | 40 | 43 | 51 | 56 | 54 | 68 | 75 | 79 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 714 | 711 | 711 | 704 | 698 | 688 | 684 | 673 | 668 | 659 | 653 | 633 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | -1 | -1 | -0 | -1 | ||||||
| Retained Earnings Accumulated Deficit | -293 | -339 | -340 | -351 | -351 | -336 | -335 | -348 | -346 | -325 | -315 | -300 | ||||||
| Stockholders Equity | 420 | 372 | 372 | 354 | 347 | 353 | 349 | 325 | 321 | 333 | 338 | 332 | ||||||
| Liabilities And Stockholders Equity | 447 | 401 | 406 | 392 | 387 | 395 | 399 | 382 | 375 | 402 | 413 | 411 | ||||||
| Series A Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | ||||||
| Common Stock Shares Issued | 49 | 49 | 48 | 48 | 48 | 48 | 47 | 46 | 46 | 46 | 45 | 44 | ||||||
| Shares Outstanding | 49 | 49 | 48 | 48 | 48 | 48 | 47 | 46 | 46 | 46 | 45 | 44 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBIOLIFE SOLUTIONS INC (BLFS) — SEC Financial Statements & Analysis
BIOLIFE SOLUTIONS INC (BLFS) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. BIOLIFE SOLUTIONS INC trades on Nasdaq as: BLFS. BIOLIFE SOLUTIONS INC (BLFS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, BIOLIFE SOLUTIONS INC carries a market cap of $1.38B, a P/E ratio of 23.80x, a P/B ratio of 3.29x, a P/S ratio of 12.93x, an enterprise value of $1.36B, and an EV/EBITDA multiple of 395.57x. On profitability, it posts a gross margin of 63.45%, an operating margin of 1.64%, a net margin of 54.35%, a Return on Equity (ROE) of 15.12%, a Return on Assets (ROA) of 13.89%, and a Return on Invested Capital (ROIC) of 0.48%. Per share, it reports EPS of $1.19, diluted EPS of $1.18, free cash flow per share of $0.32, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 30.12% year-over-year, net income growth of -1148.48% year-over-year, and EPS growth of -1125.55% year-over-year. On the balance sheet, it maintains a current ratio of 9.69x, a quick ratio of 6.67x, working capital of $121.25M, a debt-to-equity ratio of 0.07x, a debt ratio of 0.06, an interest coverage ratio of 0.52x, free cash flow of $15.67M (TTM), and net debt of $-24.00M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.38B
- P/E TTM
- 23.80x
- EPS TTM
- $1.19
- P/B TTM
- 3.29x
- ROE TTM
- 15.12%
- ROA TTM
- 13.89%
- Debt To Equity
- 0.07x
- Free Cash Flow TTM
- $15.67M
- Net Revenue TTM Growth 1Y
- 30.12%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BIOLIFE SOLUTIONS INC in?
BIOLIFE SOLUTIONS INC (BLFS) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does BLFS trade on?
BIOLIFE SOLUTIONS INC (BLFS) trades on the Nasdaq.
Where is BIOLIFE SOLUTIONS INC incorporated?
BIOLIFE SOLUTIONS INC is incorporated in DE.
When was BIOLIFE SOLUTIONS INC (BLFS)'s most recent SEC filing?
BIOLIFE SOLUTIONS INC (BLFS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is BLFS's market cap?
BIOLIFE SOLUTIONS INC (BLFS) has a market capitalization of $1.38B as of 2026-06-30.
What is BLFS's P/E ratio?
BIOLIFE SOLUTIONS INC (BLFS)'s trailing twelve month P/E ratio is 23.80x as of 2026-06-30.
What is BLFS's EPS (earnings per share)?
BIOLIFE SOLUTIONS INC (BLFS)'s trailing twelve month EPS is $1.19 as of 2026-06-30.
What is BLFS's ROE (return on equity)?
BIOLIFE SOLUTIONS INC (BLFS)'s trailing twelve month Return on Equity (ROE) is 15.12% as of 2026-06-30.
What is BLFS's ROA (return on assets)?
BIOLIFE SOLUTIONS INC (BLFS)'s trailing twelve month Return on Assets (ROA) is 13.89% as of 2026-06-30.
What is BLFS's ROIC (return on invested capital)?
BIOLIFE SOLUTIONS INC (BLFS)'s trailing twelve month Return on Invested Capital (ROIC) is 0.48% as of 2026-06-30.
What is BLFS's EV/EBITDA?
BIOLIFE SOLUTIONS INC (BLFS)'s trailing twelve month EV/EBITDA is 395.57x as of 2026-06-30.